Haemonetics Corporation (HAE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haemonetics Corporation (HAE) has a cash flow conversion efficiency ratio of 0.089x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($70.94 Million) by net assets ($796.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HAE net asset quality index to measure how much of total assets are equity-financed.
Haemonetics Corporation - Cash Flow Conversion Efficiency Trend (1992–2026)
This chart illustrates how Haemonetics Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check HAE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Haemonetics Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haemonetics Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hub Group Inc
NASDAQ:HUBG
|
0.016x |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
-0.032x |
|
Hufvudstaden AB (publ)
ST:HUFV-A
|
0.013x |
|
KANSAI PAINT SPON.ADR/1/2
F:KAP0
|
N/A |
|
Thanachart Capital Public Company Limited
BK:TCAP
|
0.007x |
|
Emerald Resources NL
AU:EMR
|
0.028x |
|
SoundHound AI Inc
NASDAQ:SOUN
|
-0.057x |
|
The Andersons Inc
NASDAQ:ANDE
|
-0.301x |
Annual Cash Flow Conversion Efficiency for Haemonetics Corporation (1992–2026)
The table below shows the annual cash flow conversion efficiency of Haemonetics Corporation from 1992 to 2026. For the full company profile with market capitalisation and key ratios, see market value of Haemonetics Corporation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $893.76 Million | $293.22 Million | 0.328x | +48.19% |
| 2025-03-31 | $820.84 Million | $181.72 Million | 0.221x | +16.93% |
| 2024-03-31 | $959.96 Million | $181.75 Million | 0.189x | -43.28% |
| 2023-03-31 | $818.00 Million | $273.06 Million | 0.334x | +45.22% |
| 2022-03-31 | $749.42 Million | $172.26 Million | 0.230x | +54.57% |
| 2021-03-31 | $731.67 Million | $108.81 Million | 0.149x | -44.82% |
| 2020-03-31 | $587.11 Million | $158.22 Million | 0.269x | +13.00% |
| 2019-03-31 | $667.87 Million | $159.28 Million | 0.238x | -18.56% |
| 2018-03-31 | $752.43 Million | $220.35 Million | 0.293x | +35.59% |
| 2017-03-31 | $739.61 Million | $159.74 Million | 0.216x | +27.60% |
| 2016-03-31 | $719.98 Million | $121.86 Million | 0.169x | +9.95% |
| 2015-03-31 | $826.12 Million | $127.18 Million | 0.154x | -7.36% |
| 2014-03-31 | $839.61 Million | $139.52 Million | 0.166x | +50.25% |
| 2013-03-31 | $769.18 Million | $85.07 Million | 0.111x | -29.50% |
| 2012-03-31 | $735.08 Million | $115.32 Million | 0.157x | -12.81% |
| 2011-03-31 | $686.14 Million | $123.45 Million | 0.180x | -18.33% |
| 2010-03-31 | $593.12 Million | $130.67 Million | 0.220x | +2.21% |
| 2009-03-31 | $539.88 Million | $116.36 Million | 0.216x | +37.14% |
| 2008-03-31 | $494.19 Million | $77.67 Million | 0.157x | -9.79% |
| 2007-03-31 | $479.65 Million | $83.56 Million | 0.174x | -10.13% |
| 2006-03-31 | $441.65 Million | $85.62 Million | 0.194x | -3.32% |
| 2005-03-31 | $355.13 Million | $71.21 Million | 0.201x | -24.82% |
| 2004-03-31 | $279.75 Million | $74.61 Million | 0.267x | +36.35% |
| 2003-03-31 | $223.24 Million | $43.67 Million | 0.196x | +43.70% |
| 2002-03-31 | $236.82 Million | $32.24 Million | 0.136x | -51.91% |
| 2001-03-31 | $215.52 Million | $61.01 Million | 0.283x | +9.31% |
| 2000-03-31 | $206.44 Million | $53.47 Million | 0.259x | +70.53% |
| 1999-03-31 | $221.90 Million | $33.70 Million | 0.152x | +44.95% |
| 1998-03-31 | $194.70 Million | $20.40 Million | 0.105x | -11.59% |
| 1997-03-31 | $225.30 Million | $26.70 Million | 0.119x | -53.07% |
| 1996-03-31 | $217.00 Million | $54.80 Million | 0.253x | +212.75% |
| 1995-03-31 | $193.20 Million | $15.60 Million | 0.081x | -51.91% |
| 1994-03-31 | $160.80 Million | $27.00 Million | 0.168x | -40.74% |
| 1993-03-31 | $126.70 Million | $35.90 Million | 0.283x | +36.55% |
| 1992-03-31 | $90.60 Million | $18.80 Million | 0.208x | -- |
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more